.grx-pd { /* no font-size: inherits the theme's body text size so this block matches surrounding UI on both Shopify and Zoey */ max-width: 760px; font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, Arial, sans-serif; color: #1a1a1a; line-height: 1.5; } .grx-pd__intro { font-size: 1em; margin: 0 0 1.75rem; } /* em = relative to inherited body size */ .grx-pd__intro strong { color: #0f0f0f; } /* auto-fit grid: cards reflow from 1 col on mobile to 2 on wider screens without media queries */ .grx-pd__grid { display: grid; grid-template-columns: repeat(auto-fit, minmax(260px, 1fr)); gap: 14px; margin: 0 0 2rem; } .grx-pd__card { background: #f7f8fa; color: #3d3d3d; border-radius: 0; padding: 16px 18px; font-size: 1em; /* matches theme body text exactly */ transition: box-shadow .15s ease, transform .15s ease; } .grx-pd__card:hover { /* subtle lift signals these are discrete data points, not a plain list */ box-shadow: 0 4px 14px rgba(0,0,0,.06); } .grx-pd__card-title { /* larger + heavier than body so the mechanism reads first, body copy second */ display: block; font-size: 1em; font-weight: 700; color: #0f0f0f; margin: 0 0 .5rem; line-height: 1.5; } /* disclaimer intentionally low-contrast + small: legally present, visually de-emphasized */ .grx-pd__legal { border-top: 1px solid #e6e8ec; padding-top: 1.5rem; font-size: 1em; color: #6b7280; line-height: 1.55; } .grx-pd__legal p { margin: 0 0 .6rem; font-size: 1em;} .grx-pd__legal p:last-child { margin-bottom: 0; } Ipamorelin is a selective growth hormone secretagogue peptide that acts on the pituitary gland to stimulate the release of growth hormone through activation of the ghrelin receptor (GHS-R1a). Its mechanism involves mimicking endogenous ghrelin, promoting pulsatile secretion of growth hormone while exhibiting minimal influence on appetite-regulating pathways. This profile supports its use in clinical protocols requiring modulation of growth hormone dynamics. GHS-R1a Selective ActivationIpamorelin demonstrates selective activation of the growth hormone secretagogue receptor, leading to increased endogenous growth hormone release. Cortisol & Prolactin SparingIpamorelin exhibits a favorable safety profile with limited impact on cortisol and prolactin secretion compared to other secretagogues. Anabolic Process SupportIpamorelin has been evaluated in peer-reviewed literature for its potential role in supporting anabolic processes associated with lean body mass maintenance. Appetite Pathway DistinctionIpamorelin shows minimal stimulation of appetite-related pathways, distinguishing it from other growth hormone releasing peptides. Pulsatile GH PreservationIpamorelin may support physiological growth hormone pulsatility without significant desensitization in preclinical models. This product is intended for use by licensed healthcare providers in clinical settings. It is not intended for consumer sale. Buyer/doctor has determined and documented that the use of this product is appropriate for the patient based on the assessment of the patient's needs. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. For professional use only.
Related
Related
Related